MIP and kidney cancer: The results showed that the expression levels of AQP0/1/2/3/4/5/7/8/11 in kidney cancer were significantly lower than those in normal tissues, while the expression level of AQP6 was up-regulated or down-regulated in different test results, which was inconsistent.